| Year |
Citation |
Score |
| 2018 |
Kim JH, Frantz AM, Anderson KL, Graef AJ, Scott MC, Robinson S, Sharkey LC, O'Brien TD, Dickerson EB, Modiano JF. Corrigendum to: "Interleukin-8 promotes canine hemangiosarcoma growth by regulating the tumor microenvironment" [Exp. Cell. Res. 2014 15 323(1) 155-64]. Experimental Cell Research. PMID 30017210 DOI: 10.1016/J.Yexcr.2018.07.012 |
0.564 |
|
| 2017 |
Kim JH, Frantz AM, Sarver AL, Gorden Klukas BH, Lewellen M, O'Brien TD, Dickerson EB, Modiano JF. Modulation of fatty acid metabolism and immune suppression are features of in vitro tumour sphere formation in ontogenetically distinct dog cancers. Veterinary and Comparative Oncology. PMID 29152836 DOI: 10.1111/Vco.12368 |
0.58 |
|
| 2015 |
Tonomura N, Elvers I, Thomas R, Megquier K, Turner-Maier J, Howald C, Sarver AL, Swofford R, Frantz AM, Ito D, Mauceli E, Arendt M, Noh HJ, Koltookian M, Biagi T, et al. Genome-wide association study identifies shared risk loci common to two malignancies in golden retrievers. Plos Genetics. 11: e1004922. PMID 25642983 DOI: 10.1371/Journal.Pgen.1004922 |
0.592 |
|
| 2014 |
Khammanivong A, Gorden BH, Frantz AM, Graef AJ, Dickerson EB. Identification of drug-resistant subpopulations in canine hemangiosarcoma. Veterinary and Comparative Oncology. PMID 25112808 DOI: 10.1111/Vco.12114 |
0.34 |
|
| 2014 |
Ito D, Frantz AM, Modiano JF. Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: recent progress and applications. Veterinary Immunology and Immunopathology. 159: 192-201. PMID 24642290 DOI: 10.1016/J.Vetimm.2014.02.016 |
0.545 |
|
| 2014 |
Kim JH, Frantz AM, Anderson KL, Graef AJ, Scott MC, Robinson S, Sharkey LC, O'Brien TD, Dickerson EB, Modiano JF. Interleukin-8 promotes canine hemangiosarcoma growth by regulating the tumor microenvironment. Experimental Cell Research. 323: 155-64. PMID 24582862 DOI: 10.1016/J.Yexcr.2014.02.020 |
0.531 |
|
| 2014 |
Gorden BH, Kim JH, Sarver AL, Frantz AM, Breen M, Lindblad-Toh K, O'Brien TD, Sharkey LC, Modiano JF, Dickerson EB. Identification of three molecular and functional subtypes in canine hemangiosarcoma through gene expression profiling and progenitor cell characterization. The American Journal of Pathology. 184: 985-95. PMID 24525151 DOI: 10.1016/J.Ajpath.2013.12.025 |
0.593 |
|
| 2013 |
Schappa JT, Frantz AM, Gorden BH, Dickerson EB, Vallera DA, Modiano JF. Hemangiosarcoma and its cancer stem cell subpopulation are effectively killed by a toxin targeted through epidermal growth factor and urokinase receptors. International Journal of Cancer. 133: 1936-44. PMID 23553371 DOI: 10.1186/1753-6561-7-S2-P34 |
0.568 |
|
| 2013 |
Frantz AM, Sarver AL, Ito D, Phang TL, Karimpour-Fard A, Scott MC, Valli VE, Lindblad-Toh K, Burgess KE, Husbands BD, Henson MS, Borgatti A, Kisseberth WC, Hunter LE, Breen M, et al. Molecular profiling reveals prognostically significant subtypes of canine lymphoma. Veterinary Pathology. 50: 693-703. PMID 23125145 DOI: 10.1177/0300985812465325 |
0.604 |
|
| 2013 |
Kim J, Anderson KL, Frantz AM, Graef AJ, Scott MC, Sharkey LC, O’Brien TD, Dickerson EB, Modiano JF. Constitutive expression and roles of interleukin-8 in canine hemangiosarcoma Bmc Proceedings. 7. DOI: 10.1186/1753-6561-7-S2-P35 |
0.504 |
|
| 2012 |
Ito D, Frantz AM, Williams C, Thomas R, Burnett RC, Avery AC, Breen M, Mason NJ, O'Brien TD, Modiano JF. CD40 ligand is necessary and sufficient to support primary diffuse large B-cell lymphoma cells in culture: a tool for in vitro preclinical studies with primary B-cell malignancies. Leukemia & Lymphoma. 53: 1390-8. PMID 22229753 DOI: 10.3109/10428194.2011.654337 |
0.626 |
|
| Show low-probability matches. |